Navigation Links
Enzyme offers new therapeutic target for cancer drugs
Date:6/21/2012

Researchers at the University of California, San Diego School of Medicine have uncovered a new signal transduction pathway specifically devoted to the regulation of alternative RNA splicing, a process that allows a single gene to produce or code multiple types of protein variants. The discovery, published in the June 27, 2012 issue of Molecular Cell, suggests the new pathway might be a fruitful target for new cancer drugs.

Signal transduction in the cell involves kinases and phosphatases, enzymes that transfer or remove phosphates in protein molecules in a cascade or pathway. SRPK kinases, first described by Xiang-Dong Fu, PhD, professor of cellular and molecular medicine at UC San Diego in 1994, are involved in controlling the activities of splicing regulators in mammalian cells.

Prior studies have implicated SRPK1 in cancer and other human diseases. For example, it has been shown that SRPK1 plays a critical role in regulating the function of Vascular Endothelial Growth Factor or VEGF, which stimulates blood vessel growth in cancer. SRPK1 has been found to be dysregulated in a number of cancers, from kidney and breast to lung and pancreatic.

Conversely, studies suggest the absence of SRPK1 may be problematic as well, at least in terms of controlling some specific cancer phenotypes. Reduced SRPK1, for example, has been linked to drug resistance, a major problem in chemotherapy of cancer.

In their new paper, Fu and colleagues place SRPK1 in a major signal transduction pathway in the cell. "The kinase sits right in the middle of the PI3K-Akt pathway to specifically relay the growth signal to regulate alternative splicing in the nucleus," said Fu. "It's a new signaling branch that has previously escaped detection."

As such, the SRPK offers a new target for disease intervention and treatment, researchers say. "It's a good target because of its central role and because it can be manipulated with compounds that suppress its activity, which appears quite effective in suppressing blood vessel formation in cancer," Fu said.


'/>"/>
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Enzyme corrects more than 1 million faults in DNA replication
2. Mayo Clinic offers newly approved treatment for acid reflux disease
3. Wilderness Medicine founder offers health tips for summer season
4. Botox Offers Little Relief for Migraine, Study Finds
5. Prosthetic retina offers simple solution to restoring sight
6. Study Offers Ways to Decrease Use of Restraints at Nursing Homes
7. Skin transplant offers new hope for vitiligo patients
8. New molecular structure offers first picture of a protein family vital to human health
9. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
10. SYNERGY HomeCare Offers Free Home Safety Assessments
11. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... CO (PRWEB) , ... January 17, 2017 , ... ... protection and financial planning assistance to families and business professionals throughout central Colorado, ... to regional homeless families. , The Aurora Warms The Night organization is committed ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... survivor Sandra Lee as keynote speaker for the 34th Annual Miami Breast Cancer ... making the announcement, PER® president, Phil Talamo, said, “We are delighted to have ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , a global ... a new agreement as part of a long-term extension of their media partnership. The ... airing of some of the sport’s premier events exclusively on FloWrestling.com as well as ...
(Date:1/16/2017)... ... January 16, 2017 , ... California Southern University has named Dr. ... CalSouthern’s Board of Trustees and as a core faculty member, teaching master’s and doctoral ... professor of psychology at Pepperdine University, where he earned his Doctor of Psychology degree ...
(Date:1/16/2017)... ... January 16, 2017 , ... Anybody who may be looking for ... new video released by Serenity Recovery, a holistic treatment center for addiction located in ... features footage and testimonials from patients and staff that visited the 2016 Recovery Palooza ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- In a letter to President-elect Donald J. Trump ... AARP,s priorities for Americans age 50 and older including ... health care coverage, and lowering the cost of prescription ... President-elect Trump that "Our nearly 38 million members nationwide ... protect their Medicare and Social Security benefits, protect their ...
(Date:1/17/2017)... , Jan. 17, 2017   Anesthesia ... billing and practice management for the anesthesia and ... marijuana, which remains a "clinical conundrum" (as described ... chronic pain practitioners to think carefully before recommending ... 395-page report by the National Academies of Sciences, ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 ... clinical stage biopharmaceutical company, announced today that it will ... International Symposium on Acute Leukemias (ISAL) XVI in ... symposium is entitled:  "Reinforcing the Efficacy of Immunotherapy for ... will take place on Monday February 20 th , 2017 ...
Breaking Medicine Technology: